A business in context

MNOV research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-25 · 0001213900-26-104739

  2. 8-K · Current report

    Report date 2026-09-23 · 0001193125-26-405318 · Items 1.01

  3. 8-K · Current report

    Report date 2026-08-31 · 0001193125-26-379348 · Items 1.02

  4. 8-K · Current report

    Report date 2026-08-17 · 0001193125-26-356146 · Items 5.02

  5. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-349323

  6. 4 · Ownership change

    Report date 2026-06-23 · 0001683168-26-005111

  7. 4 · Ownership change

    Report date 2026-06-23 · 0001683168-26-005110

  8. 4 · Ownership change

    Report date 2026-06-23 · 0001683168-26-005109

  9. 8-K · Current report

    Report date 2026-06-23 · 0001193125-26-281171 · Items 5.07

  10. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-224066

  11. DEF 14A · Proxy statement

    Report date 2026-06-23 · 0001193125-26-191866

  12. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-100432

  13. 8-K · Current report

    Report date 2026-02-20 · 0001193125-26-060232 · Items 2.02,9.01

  14. 4 · Ownership change

    Report date 2026-01-16 · 0001683168-26-000430

  15. 4 · Ownership change

    Report date 2026-01-16 · 0001683168-26-000428

  16. 8-K · Current report

    Report date 2025-12-29 · 0001193125-25-335917 · Items 1.01,9.01

  17. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-277779

  18. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-109041

  19. 8-K · Current report

    Report date 2025-07-30 · 0001193125-25-170744 · Items 1.01,9.01

  20. 4 · Ownership change

    Report date 2025-06-17 · 0001683168-25-004651

  21. 4 · Ownership change

    Report date 2025-06-17 · 0001683168-25-004649

  22. 8-K · Current report

    Report date 2025-06-17 · 0000950170-25-087924 · Items 5.07

  23. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-070461

  24. DEF 14A · Proxy statement

    Report date 2025-06-17 · 0000950170-25-059321

  25. 8-K · Current report

    Report date 2025-03-11 · 0001193125-25-051990 · Items 7.01,9.01

  26. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-023301

  27. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-126343

  28. 10-Q · Quarterly report

    Report date 2024-06-30 · 0000950170-24-094092

  29. 8-K · Current report

    Report date 2024-06-11 · 0000950170-24-072461 · Items 5.07

  30. 10-Q · Quarterly report

    Report date 2024-03-31 · 0000950170-24-056996

  31. DEF 14A · Proxy statement

    Report date 2024-06-11 · 0000950170-24-049146

  32. 8-K · Current report

    Report date 2024-03-26 · 0001193125-24-083356 · Items 5.02

  33. 10-K · Annual report

    Report date 2023-12-31 · 0000950170-24-015920

  34. 10-Q · Quarterly report

    Report date 2023-09-30 · 0000950170-23-062079

  35. 10-Q · Quarterly report

    Report date 2023-06-30 · 0000950170-23-040621

  36. 8-K · Current report

    Report date 2023-08-04 · 0001193125-23-204956 · Items 5.02

  37. 8-K · Current report

    Report date 2023-06-15 · 0001193125-23-172585 · Items 3.01

  38. 8-K · Current report

    Report date 2023-06-13 · 0000950170-23-027823 · Items 5.07

  39. 10-Q · Quarterly report

    Report date 2023-03-31 · 0000950170-23-021279

  40. 8-K · Current report

    Report date 2023-04-20 · 0001193125-23-118572 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 1 transaction rows1SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-25
2026-09-29
3D Investment Partners Pte. Ltd.; 3D Opportunity Master FundS · Sale
Disposed
Common Stock640000.02.7

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001226616MEDICINOVA INC

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2023-12-31$1.00M$1.11M
    2021-12-31$4.04M$5.02M

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗